Cancer detection rates of the PI-RADSv2.1 assessment categories: systematic review and meta-analysis on lesion level and patient level.

Benedict OertherHannes EngelFabian BambergAugust SigleChristian GratzkeMatthias Benndorf

Published in: Prostate cancer and prostatic diseases (2021)

Our estimates of CDR demonstrate that PI-RADSv2.1 stratifies lesions and patients as intended. Our results might serve as an initial evidence base to discuss management strategies linked to assessment categories.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
papillary thyroid
case report
squamous cell carcinoma
squamous cell
patient reported outcomes
young adults
label free
real time pcr